Data through FY2026 Q3 (Jun 30, 2026)
Otsuka Pharmaceutical Development & Commercialization, Inc.
Company profile for Otsuka Pharmaceutical Development & Commercialization, Inc. covers 32 filings across the reporting window. FY2026 certified median offer: $175,000.
- FY2026 certified median
- $175,000
- Total filings
- 32
- FY2026 25th–75th percentile
- $160,978–$211,218
- Top job title
- Director, Global Value Evidence Strategy
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 13 | $170,000 | $150,481 | $176,250 |
| FY2025 | 8 | $172,500 | $163,750 | $185,000 |
| FY2026 (Q1–Q3) | 11 | $175,000 | $160,978 | $211,218 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Director, Global Value Evidence Strategy4 filings
- Senior Manager, Statistical Programming4 filings
- Senior Project Data Manager3 filings
- Manager, Biostatistics2 filings
- Manager-Regulatory operations2 filings
- Asset Manager1 filings
- Assoc. Director, Data Programmer, Real World Data Analytics1 filings
- Associate Director, Data Engineer1 filings
- Associate Director, Global Quality Operations1 filings
- Associate Director, Regulatory Operations1 filings
Top cities
- Princeton28 filings
- Overland Park2 filings
- Waltham1 filings
- Irving1 filings